Clinical Trials Sponsored by Sorgente BV

Total 359 results

AstraZeneca
Acerta Pharma BV

Completed

A Study to Evaluate Effects of Proton-pump Inhibitor on Acalabrutinib Capsule When Administered Orally With COCA-COLA in Healthy Participants

Infectious Disease

United States
Philips Electronics Nederland BV

Completed

Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D.

Psoriasis Vulgaris

Germany
Philips Electronics Nederland BV

Completed

Blue Light Device for Pain Therapy (PAINCT02)

Low Back Pain | Musculoskeletal Pain | Chronic Pain | Low Back Pain, Recurrent

Germany
Centocor, Inc.
Centocor BV

Completed

A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

Crohn Disease
Sorrento Therapeutics, Inc.

Not yet recruiting

Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors

Advanced Solid Tumor

United States
Sorrento Therapeutics, Inc.

Recruiting

Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Sorrento Therapeutics, Inc.

Recruiting

Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis

Light Chain (AL) Amyloidosis

United States
Sorrento Therapeutics, Inc.

Withdrawn

A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

Diffuse Large B Cell Lymphoma | Biliary Tract Cancer | Peripheral T Cell Lymphoma | Extranodal NK T Cell Lymphoma, Nasal
Sorrento Therapeutics, Inc.

Terminated

Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)

Covid19

United Kingdom
Sorrento Therapeutics, Inc.

Enrolling by invitation

Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy

Long-term Follow-up

United States
Sorrento Therapeutics, Inc.

Withdrawn

Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

Malignant Tumor of Pancreas Metastatic to Liver
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19

Covid19
Sorrento Therapeutics, Inc.

Withdrawn

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Pain, Intractable | Pain Cancer
Sorrento Therapeutics, Inc.

Withdrawn

Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress

Covid19 | ARDS

United States
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19

Covid19
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19

Covid-19
Sorrento Therapeutics, Inc.

Completed

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer (TRIBECA)

Metastatic Breast Cancer | Locally Recurrent Breast Cancer

United States, Georgia, Moldova, Republic of, Romania, Serbia, Singapore, Ukraine
Sorrento Therapeutics, Inc.

Not yet recruiting

Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors

Sarcoma | Cancer | Solid Tumor | Cancer of Pancreas | Hepatic Metastasis
Sorrento Therapeutics, Inc.

Recruiting

Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors

Solid Tumor | Refractory Tumor | Relapsed Solid Neoplasm

United States
Sorrento Therapeutics, Inc.

Withdrawn

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise (BR)

Covid19
Sorrento Therapeutics, Inc.

Withdrawn

An Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL Amyloidosis

Light Chain (AL) Amyloidosis
Sorrento Therapeutics, Inc.

Active, not recruiting

Study to Assess Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Sorrento Therapeutics, Inc.

Active, not recruiting

Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents

COVID-19

United States
Sorrento Therapeutics, Inc.

Withdrawn

Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors

Solid Tumor, Adult | Refractory Cancer | Relapsed Solid Neoplasm
Sorrento Therapeutics, Inc.

Completed

Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 (SOC)

Covid-19

United States
Sorrento Therapeutics, Inc.

Terminated

Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases (AntiCEA_CART)

Metastatic Pancreatic Carcinoma

United States
Sorrento Therapeutics, Inc.

Active, not recruiting

Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis

Knee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic

United States
Sorrento Therapeutics, Inc.

Terminated

Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress

Covid19

Brazil
Sorrento Therapeutics, Inc.

Withdrawn

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Carcinoembryonic Antigen

United States
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms

Covid19

United States
Sorrento Therapeutics, Inc.

Completed

Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US)

Covid19

United States
Sorrento Therapeutics, Inc.

Withdrawn

Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection (US)

COVID-19
Maastricht University Medical Center
SenterNovem; Newtricious BV; Globus Ei BV

Completed

The Effect of Eggs and Egg Products on Macular Pigment

Age-related Macular Degeneration

Netherlands
CoreAalst BV
HeartFlow, Inc.

Recruiting

The COMPLETE Study (COMPLETE)

Coronary Artery Disease

Belgium
Acerta Pharma BV
AstraZeneca

Active, not recruiting

A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL

Mantle Cell Lymphoma (MCL)

United States, Poland, Italy
Acerta Pharma BV
AstraZeneca

Active, not recruiting

Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies

Multiple Myeloma | Non-Hodgkins Lymphoma | B-All

United States
Acerta Pharma BV
AstraZeneca

Active, not recruiting

Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma

Non Hodgkin Lymphoma

United States, Canada, Italy
Acerta Pharma BV
AstraZeneca

Active, not recruiting

A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312) (ESCALADE)

Diffuse Large B-Cell Lymphoma

United States, France, Italy, Spain, Canada, Taiwan, Germany, Korea, Republic of, Brazil, Japan, Russian Federation, Poland, China, Israel, Belgium, Australia, Austria, Czechia, Portugal, Mexico, Turkey, India, Ukraine
Amphera BV
TMC Pharma

Completed

DENdritic Cell Immunotherapy for Mesothelioma (DENIM)

Mesothelioma

Netherlands, France, United Kingdom, Belgium, Italy
AtriCure, Inc.
Cardialysis BV

Active, not recruiting

Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation (CEASE-AF)

Atrial Fibrillation | Persistent and Longstanding Persistent Atrial Fibrillation

Germany, United Kingdom, Netherlands, Czechia, Poland
GATT Technologies BV
Avania

Completed

Clinical Safety and Performance of GATT-Patch in Open Liver Surgery

Hemorrhage, Surgical

Netherlands
Acerta Pharma BV
AstraZeneca

Completed

Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its Metabolite

Hepatic Insufficiency | Healthy Subjects | Hepatic Impairment

United States
Philips Electronics Nederland BV

Completed

Blue Light for Treating Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Univar BV
Aptiv Solutions

Completed

A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Wilson's Disease

Germany
Newtricious R&D BV

Completed

Effect of NWT-03 on Blood Pressure

Blood Pressure | Albuminuria

Ireland
Centocor, Inc.
Centocor BV

Completed

A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

Ankylosing Spondylitis
Cryotherapeutics SA
CoreAalst BV

Recruiting

Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With NSTEMI or Unstable Angina (POLARSTAR)

Myocardial Infarction | Coronary Artery Disease | Cryotherapy Effect | Coronary Syndrome | Atherosclerosis, Coronary | Myocardial Disease

Lithuania, Georgia
Wageningen University
WholeFiber BV

Not yet recruiting

Impact of a Dried Vegetable on Bowel Function and Gut Microbiota

Bowel Function Dissatisfaction

Netherlands
Aesculape CRO Belgium BV

Recruiting

Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis

Acute Vulvovaginal Candidiasis

Belgium

3

Subscribe